Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Abschlussarbeit Buch |
Sprache: | English |
Veröffentlicht: |
Berlin
2021
|
Schlagworte: | |
Beschreibung: | XVI, 138 Seiten Illustrationen, Diagramme |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV047829478 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 220210s2021 a||| m||| 00||| eng d | ||
035 | |a (OCoLC)1296362295 | ||
035 | |a (DE-599)BVBBV047829478 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-188 | ||
100 | 1 | |a Grunewald, Laura |e Verfasser |0 (DE-588)1251493580 |4 aut | |
245 | 1 | 0 | |a Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy |c by Laura Grunewald, M. Sc. |
264 | 1 | |a Berlin |c 2021 | |
300 | |a XVI, 138 Seiten |b Illustrationen, Diagramme | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
502 | |b Dissertation |c Freie Universität Berlin |d 2021 | ||
655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
776 | 0 | 8 | |i Erscheint auch als |n Mikrofiche-Ausgabe |a Grunewald, Laura |t Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy |w (DE-604)BV047829453 |
999 | |a oai:aleph.bib-bvb.de:BVB01-033212749 |
Datensatz im Suchindex
_version_ | 1804183376881516544 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Grunewald, Laura |
author_GND | (DE-588)1251493580 |
author_facet | Grunewald, Laura |
author_role | aut |
author_sort | Grunewald, Laura |
author_variant | l g lg |
building | Verbundindex |
bvnumber | BV047829478 |
ctrlnum | (OCoLC)1296362295 (DE-599)BVBBV047829478 |
format | Thesis Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01131nam a2200277 c 4500</leader><controlfield tag="001">BV047829478</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">220210s2021 a||| m||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1296362295</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV047829478</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-188</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Grunewald, Laura</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1251493580</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy</subfield><subfield code="c">by Laura Grunewald, M. Sc.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVI, 138 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Freie Universität Berlin</subfield><subfield code="d">2021</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Mikrofiche-Ausgabe</subfield><subfield code="a">Grunewald, Laura</subfield><subfield code="t">Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy</subfield><subfield code="w">(DE-604)BV047829453</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033212749</subfield></datafield></record></collection> |
genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
genre_facet | Hochschulschrift |
id | DE-604.BV047829478 |
illustrated | Illustrated |
index_date | 2024-07-03T19:08:56Z |
indexdate | 2024-07-10T09:22:28Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033212749 |
oclc_num | 1296362295 |
open_access_boolean | |
owner | DE-188 |
owner_facet | DE-188 |
physical | XVI, 138 Seiten Illustrationen, Diagramme |
publishDate | 2021 |
publishDateSearch | 2021 |
publishDateSort | 2021 |
record_format | marc |
spelling | Grunewald, Laura Verfasser (DE-588)1251493580 aut Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy by Laura Grunewald, M. Sc. Berlin 2021 XVI, 138 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Dissertation Freie Universität Berlin 2021 (DE-588)4113937-9 Hochschulschrift gnd-content Erscheint auch als Mikrofiche-Ausgabe Grunewald, Laura Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy (DE-604)BV047829453 |
spellingShingle | Grunewald, Laura Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy |
subject_GND | (DE-588)4113937-9 |
title | Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy |
title_auth | Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy |
title_exact_search | Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy |
title_exact_search_txtP | Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy |
title_full | Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy by Laura Grunewald, M. Sc. |
title_fullStr | Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy by Laura Grunewald, M. Sc. |
title_full_unstemmed | Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy by Laura Grunewald, M. Sc. |
title_short | Improving preclinical evaluation and therapeutic efficacy of neuroblastoma-specific chimeric antigen receptor T cell therapy |
title_sort | improving preclinical evaluation and therapeutic efficacy of neuroblastoma specific chimeric antigen receptor t cell therapy |
topic_facet | Hochschulschrift |
work_keys_str_mv | AT grunewaldlaura improvingpreclinicalevaluationandtherapeuticefficacyofneuroblastomaspecificchimericantigenreceptortcelltherapy |